These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 28128088)

  • 1. Gestational Pityriasis Rosea: Suggestions for Approaching Affected Pregnant Women.
    Monastirli A; Pasmatzi E; Badavanis G; Tsambaos D
    Acta Dermatovenerol Croat; 2016 Dec; 24(4):312-313. PubMed ID: 28128088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pityriasis Rosea during Pregnancy: Major and Minor Alarming Signs.
    Drago F; Ciccarese G; Herzum A; Rebora A; Parodi A
    Dermatology; 2018; 234(1-2):31-36. PubMed ID: 29936509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pityriasis Rosea: An Updated Review.
    Leung AKC; Lam JM; Leong KF; Hon KL
    Curr Pediatr Rev; 2021; 17(3):201-211. PubMed ID: 32964824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome in patients with pityriasis rosea.
    Drago F; Broccolo F; Zaccaria E; Malnati M; Cocuzza C; Lusso P; Rebora A
    J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S78-83. PubMed ID: 18489054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pityriasis Rosea after COVID-19 Infection.
    Prtajin M; Ljubojević Hadžavdić S
    Acta Dermatovenerol Croat; 2022 Dec; 30(4):265-266. PubMed ID: 36919396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7.
    Broccolo F; Drago F; Careddu AM; Foglieni C; Turbino L; Cocuzza CE; Gelmetti C; Lusso P; Rebora AE; Malnati MS
    J Invest Dermatol; 2005 Jun; 124(6):1234-40. PubMed ID: 15955099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human herpesvirus 7 in patients with pityriasis rosea. Electron microscopy investigations and polymerase chain reaction in mononuclear cells, plasma and skin.
    Drago F; Ranieri E; Malaguti F; Battifoglio ML; Losi E; Rebora A
    Dermatology; 1997; 195(4):374-8. PubMed ID: 9529560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pityriasis Rosea: A Comprehensive Classification.
    Drago F; Ciccarese G; Rebora A; Broccolo F; Parodi A
    Dermatology; 2016; 232(4):431-7. PubMed ID: 27096928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oropharyngeal lesions in pityriasis rosea.
    Ciccarese G; Broccolo F; Rebora A; Parodi A; Drago F
    J Am Acad Dermatol; 2017 Nov; 77(5):833-837.e4. PubMed ID: 28728872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent pityriasis rosea: an unusual form of pityriasis rosea with persistent active HHV-6 and HHV-7 infection.
    Drago F; Broccolo F; Ciccarese G; Rebora A; Parodi A
    Dermatology; 2015; 230(1):23-6. PubMed ID: 25612842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human herpesvirus 6 and 7 DNA in peripheral blood leucocytes and plasma in patients with pityriasis rosea by polymerase chain reaction: a prospective case control study.
    Chuh AA; Chiu SS; Peiris JS
    Acta Derm Venereol; 2001; 81(4):289-90. PubMed ID: 11720179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pityriasis Rosea in Children: Clinical Features and Laboratory Investigations.
    Drago F; Ciccarese G; Broccolo F; Cozzani E; Parodi A
    Dermatology; 2015; 231(1):9-14. PubMed ID: 25997658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pityriasis rosea and herpesviruses: facts and controversies.
    Rebora A; Drago F; Broccolo F
    Clin Dermatol; 2010; 28(5):497-501. PubMed ID: 20797508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological study of human herpesvirus-6 and human herpesvirus-7 in pityriasis rosea.
    Kosuge H; Tanaka-Taya K; Miyoshi H; Amo K; Harada R; Ebihara T; Kawahara Y; Yamanishi K; Nishikawa T
    Br J Dermatol; 2000 Oct; 143(4):795-8. PubMed ID: 11069458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of high-dose acyclovir in pityriasis rosea.
    Drago F; Vecchio F; Rebora A
    J Am Acad Dermatol; 2006 Jan; 54(1):82-5. PubMed ID: 16384760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of human herpesvirus 6, human herpesvirus 7, Epstein-Barr virus and cytomegalovirus in the aetiology of pityriasis rosea.
    Canpolat Kirac B; Adisen E; Bozdayi G; Yucel A; Fidan I; Aksakal N; Gurer MA
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):16-21. PubMed ID: 18713231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6.
    Watanabe T; Kawamura T; Jacob SE; Aquilino EA; Orenstein JM; Black JB; Blauvelt A
    J Invest Dermatol; 2002 Oct; 119(4):793-7. PubMed ID: 12406322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of human herpesvirus-6 and -7 reactivation in miscarrying women with pityriasis rosea.
    Drago F; Broccolo F; Javor S; Drago F; Rebora A; Parodi A
    J Am Acad Dermatol; 2014 Jul; 71(1):198-9. PubMed ID: 24947696
    [No Abstract]   [Full Text] [Related]  

  • 19. The saliva quantitative PCR assay is inadequate to detect and monitor human herpesvirus-7 and -6 reactivation in patients with Pityriasis rosea.
    Broccolo F; Ciccarese G; Oggioni M; Rebora A; Parodi A; Drago F
    J Clin Virol; 2014 Dec; 61(4):615-6. PubMed ID: 25453575
    [No Abstract]   [Full Text] [Related]  

  • 20. Pityriasis rosea is not associated with human herpesvirus 7.
    Kempf W; Adams V; Kleinhans M; Burg G; Panizzon RG; Campadelli-Fiume G; Nestle FO
    Arch Dermatol; 1999 Sep; 135(9):1070-2. PubMed ID: 10490111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.